SG11202104315XA - Vesicles derived from lactobacillus paracasei and use of same - Google Patents

Vesicles derived from lactobacillus paracasei and use of same

Info

Publication number
SG11202104315XA
SG11202104315XA SG11202104315XA SG11202104315XA SG11202104315XA SG 11202104315X A SG11202104315X A SG 11202104315XA SG 11202104315X A SG11202104315X A SG 11202104315XA SG 11202104315X A SG11202104315X A SG 11202104315XA SG 11202104315X A SG11202104315X A SG 11202104315XA
Authority
SG
Singapore
Prior art keywords
same
lactobacillus paracasei
vesicles derived
vesicles
derived
Prior art date
Application number
SG11202104315XA
Other languages
English (en)
Inventor
Yoon-Keun Kim
Chang Mo Moon
Original Assignee
Md Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Md Healthcare Inc filed Critical Md Healthcare Inc
Publication of SG11202104315XA publication Critical patent/SG11202104315XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202104315XA 2018-12-31 2019-08-13 Vesicles derived from lactobacillus paracasei and use of same SG11202104315XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180174027 2018-12-31
KR1020190048671A KR102098067B1 (ko) 2018-12-31 2019-04-25 락토바실러스 파라카제이 유래 소포 및 이의 용도
PCT/KR2019/010267 WO2020141685A1 (fr) 2018-12-31 2019-08-13 Vésicules dérivées de lactobacillus paracasei et utilisation correspondante

Publications (1)

Publication Number Publication Date
SG11202104315XA true SG11202104315XA (en) 2021-05-28

Family

ID=70291099

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104315XA SG11202104315XA (en) 2018-12-31 2019-08-13 Vesicles derived from lactobacillus paracasei and use of same

Country Status (13)

Country Link
EP (1) EP3912631A4 (fr)
JP (2) JP2022514977A (fr)
KR (1) KR102098067B1 (fr)
CN (1) CN113260372A (fr)
AU (1) AU2019419281B2 (fr)
BR (1) BR112021003728A2 (fr)
CA (1) CA3112889A1 (fr)
CL (1) CL2021000415A1 (fr)
MX (1) MX2021002412A (fr)
MY (1) MY195500A (fr)
PH (1) PH12021550985A1 (fr)
SG (1) SG11202104315XA (fr)
WO (1) WO2020141685A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3099668C (fr) * 2018-05-09 2023-10-03 Kobiolabs, Inc Souche de lactobacillus paracasei et utilisation associee
KR102257130B1 (ko) * 2020-06-16 2021-05-28 주식회사 엠디헬스케어 락토바실러스 파라카세이 유래 소포를 포함하는 신경질환 또는 정신질환 예방 또는 치료용 조성물
EP3957316B1 (fr) 2020-06-16 2024-02-07 MD Healthcare Inc. Composition pour prévenir ou traiter des troubles neurologiques ou mentaux comprenant des vésicules issues de lactobacillus paracasei
US20230338439A1 (en) * 2020-07-14 2023-10-26 Liscure Biosciences Co., Ltd Composition for treating brain disease comprising pediococcus inopinatus or extracellular vesicles isolated therefrom as active ingredient
KR102512516B1 (ko) 2021-04-02 2023-03-22 한국과학기술연구원 옵투시폴린 (obtusifolin), 이의 유도체, 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 퇴행성관절염의 예방 또는 치료용 약제학적 조성물
CN115305211A (zh) * 2021-05-07 2022-11-08 葡萄王生技股份有限公司 益生菌胞外泌体及其用途
EP4349354A1 (fr) * 2021-06-03 2024-04-10 MD Healthcare Inc. Vésicules extracellulaires issues de bactéries lactobacilles et leur utilisation
KR20220169403A (ko) * 2021-06-18 2022-12-27 한국생명공학연구원 락티카제이바실러스 속 또는 락토바실러스 속 균주를 유효성분으로 포함하는 암 진단, 예방 또는 치료용 조성물
KR20230015688A (ko) * 2021-07-23 2023-01-31 (주) 에이투젠 신규한 락토바실러스 파라카제이 atg-e1 균주 또는 이를 포함하는 호흡기 질환의 예방 또는 치료용 조성물
CN114085792B (zh) * 2021-11-17 2023-03-24 哈尔滨医科大学 一种用于防治结肠癌的副干酪乳杆菌及其应用
CN114540227B (zh) * 2022-02-21 2023-06-23 南京医科大学 一种具有抑制肝癌肿瘤生长的副干酪乳杆菌l511及其用途
KR20230136548A (ko) 2022-03-18 2023-09-26 주식회사 엠디헬스케어 수율이 향상된 유산균 유래 세포외소포의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087902A1 (en) * 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
KR101109744B1 (ko) * 2009-11-13 2012-03-13 충청북도 (관리부서:충청북도 농업기술원) 균체외 다당을 생성하고 건강기능성 효과를 갖는 신규한 락토바실러스 파라카제이
KR101629525B1 (ko) * 2010-01-11 2016-06-13 이화여자대학교 산학협력단 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
EP2589391B1 (fr) * 2010-07-01 2018-11-14 Rosetta Exosome Co., Ltd. Microvésicules de cellules bactériennes pour application dans le traitement du cancer
KR101427363B1 (ko) * 2011-11-23 2014-08-08 주식회사 쎌바이오텍 항암 약제학적 조성물
CN113046285A (zh) * 2012-04-06 2021-06-29 康奈尔大学 用于稳健的体液及细胞免疫应答的亚单位疫苗递送平台
KR101620815B1 (ko) 2014-05-21 2016-05-13 한국생명공학연구원 해양 진균에서 분리한 페니실리놀라이드 a를 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물
KR101644595B1 (ko) * 2014-07-11 2016-08-03 한국식품연구원 락토바실러스 파라카제이(Lactobacillus paracasei)를 유효성분으로 포함하는 Th1-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
KR20160110232A (ko) * 2015-03-11 2016-09-21 주식회사 엠디헬스케어 유산균 유래 세포밖 소포체를 유효성분으로 포함하는 염증질환의 예방 또는 치료용 조성물
CN104894021B (zh) * 2015-06-03 2018-02-09 宜兰食品工业股份有限公司 一种副干酪乳杆菌及其应用
KR102027029B1 (ko) * 2017-05-25 2019-09-30 (주)엠앤씨생명과학 유산균 함유 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물
KR101984022B1 (ko) 2017-10-31 2019-09-03 한국생산기술연구원 콤팩트하고 단순화한 사류 펌프의 디퓨저 설계 방법, 이에 의하여 설계된 디퓨저 및 이를 구비한 사류 펌프

Also Published As

Publication number Publication date
PH12021550985A1 (en) 2021-11-08
JP2023109943A (ja) 2023-08-08
WO2020141685A1 (fr) 2020-07-09
KR102098067B1 (ko) 2020-04-07
CA3112889A1 (fr) 2020-07-09
BR112021003728A2 (pt) 2021-05-25
CL2021000415A1 (es) 2021-09-20
MY195500A (en) 2023-01-26
EP3912631A1 (fr) 2021-11-24
CN113260372A (zh) 2021-08-13
EP3912631A4 (fr) 2022-11-30
AU2019419281B2 (en) 2023-11-30
MX2021002412A (es) 2021-04-28
JP2022514977A (ja) 2022-02-16
AU2019419281A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
SG11202104315XA (en) Vesicles derived from lactobacillus paracasei and use of same
SG10202112104UA (en) Lactobacillus paracasei strain and use thereof
PL3681470T3 (pl) Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
IL271025A (en) Multibiotic substances and methods of using them
IL276098A (en) Hygiene product and methods for using it
EP3366206C0 (fr) Mesure et estimation de la qualité du sommeil
EP3822338A4 (fr) Lactobacillus paracasei et-22 et son utilisation
EP3812452A4 (fr) Bifidobacterium lactis bl-99 et application associée
IL274944A (en) Coatings resistant to marine adhesion and methods for their preparation and use
EP3675991A4 (fr) Générateur de radicaux libres et procédés d'utilisation
IL281438A (en) Pyridazinones and methods of using them
IL276957A (en) Tolerogenic liposomes and methods of using them
IL283782A (en) Analosomes and methods of use
IL286481A (en) Pyridazinones and methods of using them
EP3751008A4 (fr) Nanovésicules dérivées de bactéries du genre lactococcus et leur utilisation
IL276187A (en) MICA/B antibodies and methods of use
EP3456312A4 (fr) Compositions cosmétiques probiotiques et utilisation de ces compositions cosmétiques probiotiques
EP3861219A4 (fr) Moyen de verrouillage et meuble le comprenant
EP3416623A4 (fr) Liposomes chargés d'ipa-3 et leurs procédés d'utilisation
IL287071A (en) h factor vectors and their uses
IL276053A (en) Therapeutic Gard and methods of its use
IL276792A (en) Inhaler and methods for using it
GB2615478B (en) Therapeutic and prophylactic use of microorganisms
GB201915447D0 (en) Polymorphs of avapritinib and methods of preparing the polymorphs
EP3341739A4 (fr) Peptides mutants et procédés de traitement de sujets les employant